Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for
Non-obstructive Hypertrophic Cardiomyopathy
Location: San Francisco CA, Los Angeles CA, La Jolla CA,
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07023614
Phase2, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: San Francisco CA, Los Angeles CA, Irvine CA,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for
IgA Nephropathy
Location: San Francisco CA, Stanford CA, Fresno CA, Orange CA,
Sponsor: Calliditas Therapeutics AB
Sex: All
Age: 18+
Code: NCT06712407
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: San Francisco CA, Fresno CA, Reno NV, Los Angeles CA,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
for
Spinal Fusion
Location: San Francisco CA, Redwood City CA, Sacramento CA,
Sponsor: AO Foundation, AO Spine
Sex: All
Age: 45+
Code: NCT06368245
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
for
Follicular Lymphoma
Location: San Francisco CA, Duarte CA, Austin TX, Tyler TX,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06911502
Phase3, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: San Francisco CA, Stanford CA, Duarte CA, Seattle WA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase1, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: San Francisco CA, Sacramento CA, Fresno CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: San Francisco CA, Dallas TX, Rochester MN, Nashville TN,